FITQ

Quantitative faecal immunochemical testing (FITQ) is used to aid in the diagnosis of colorectal cancer. Approximately 41,000 people are diagnosed with colorectal cancer in the UK each year and the prognosis is better in those identified with early stage cancerous lesions with over 90% of cases being treated successfully following detection.Several lower gastrointestinal symptoms can suggest colorectal cancer, including rectal bleeding, a change in bowel habits, weight loss, anaemia, abdominal pain, and blood in faeces. FITQ testing can be used in primary care to assess people who are at a low risk of colorectal cancer and help determine whether they should be referred for further investigations.